Skip to main content
FinSpry Logo
FinSpry
ANIP logo
ANIP
(NASDAQ)
ANI Pharmaceuticals, Inc.
$74.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ANI Pharmaceuticals (ANIP) Stock Price & Financial Analysis

ANI Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$74.21 - $76.27
52-Week High$99.50
52-Week Low$56.71
Open$75.10
Volume275.75K
Average Volume (3M)275.75K
Market Cap1.58B
Shares Outstanding21.23M
P/E Ratio (TTM)20.58
Price to Sales (P/S)1.83
Price to Book (P/B)2.98
EV/EBITDA7.32
Revenue (TTM)883.37M
Net Income (TTM)78.34M
Free Cash Flow (TTM)128.45M
EPS (TTM)$3.69
Profit Margin8.87%
Operating Margin11.35%
Return on Equity (ROE)14.49%
Debt to Equity0.60
50-Day MA$77.17
200-Day MA$81.25
52-Week Change11.67%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ANI Pharmaceuticals

What is the current stock price for ANIP?

As of the latest trading session, ANIP stock trades at $74.21. The 52-week range is $56.71–$99.50, with a day range of $74.21–$76.27.

What is the P/E ratio for ANIP?

ANI Pharmaceuticals's trailing P/E ratio is 20.6, meaning investors pay $20.6 for every $1 of annual earnings. ANI Pharmaceuticals operates in the Healthcare sector.

Does ANIP pay dividends?

ANI Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ANIP?

Based on 3 analysts, the consensus for ANIP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ANIP?

ANI Pharmaceuticals's market capitalization is $1.58B, classifying it as a small-cap company. ANI Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.